It is known that if left untreated, women with severe uterovaginal or vault prolapse may have hydronephrosis (1) or renal impairment.
INTRODUCTION
assessed using the Baden-Walker Halfway System. (5) All clinicians used the same classification system to assess the type and degree of prolapse in these patients during examination. Renal ultrasonography was performed by radiologists who were blinded to all clinical information. Patients diagnosed with hydronephrosis on imaging were evaluated using repeat renal ultrasonography after treatment (range 1-6 months) to determine the resolution of hydronephrosis. Resolution of hydronephrosis was defined as no residual hydronephrosis on renal ultrasonography 1-6 months after intervention. The extent of renal impairment was assessed based on evaluations of serum urea and creatinine levels.
Treatment for severe prolapse was mainly by surgeryeither vaginal hysterectomy coupled with pelvic floor repair and concomitant unilateral sacrospinous fixation, or vaginal hysterectomy with concomitant use of the Prolift mesh.
All surgeries were performed via the vaginal route by two surgeons who were both consultant urogynaecologists at our centre. Some patients either defaulted follow-up or refused surgery, opting for silicone ring pessary instead.
All statistical analyses were performed using the Statistical (Table I) . Four (16.0%) patients defaulted and were lost to follow-up.
The incidence of renal impairment was 3.3% (4/121 patients had procidentia). The serum urea (normal < 7.7 mmol/L; range 10.3-18.9 mmol/L) and creatinine (normal < 141 μmol/L; range 143-216 μmol/L) levels were found to be elevated in the study population. All four patients with renal impairment had hydronephrosis in addition to fourth degree prolapse, indicating that patients with fourth degree prolapse in the presence of hydronephrosis had a 16% chance of having renal impairment in our cohort. Post-treatment improvement in serum creatinine levels was seen in all four patients with renal impairment.
DISCUSSION
Few studies have addressed hydronephrosis and renal impairment in the presence of severe uterovaginal or vault prolapse in the local population, and the outcome of treatment in these patients. Our study provides local data and results on such patients in Singapore. The local incidence of hydronephrosis in patients with severe uterovaginal or vault prolapse was 20.6% at our centre, which was slightly higher than that reported in other studies. (1, 3, 4) We also established that 3.3% of women with severe uterovaginal or vault prolapse had mild renal impairment (serum creatinine level 143-216 μmol/L).
This incidence of renal impairment increased to 16.0% among patients who had both fourth degree prolapse and concomitant hydronephrosis.
It is well established that untreated hydronephrosis may progress to irreversible renal damage. (2, 6) In this study, there was improvement in the serum creatinine levels of the four patients with renal impairment post procedure. This suggests that the resolution of hydronephrosis results in the favourable recovery of renal function. Our results also suggest that treating prolapse with vaginal surgery leads to the complete resolution or improvement of hydronephrosis in a majority of patients. In this study, 64%
of patients showed complete resolution of hydronephrosis after surgical management. Unlike our findings, the incidence of resolution following management (95%) was much higher in a prospective study by Hui et al. This study is not without its limitations. Firstly, this was a retrospective study with a small sample size of 121 patients.
Collection of prospective data over a five-year period to increase the sample size would add value to the results of this study. Fig. 1 B r e a kd o w n o f p a t i e nt s w i t h s e v e r e u te r o v a g i n a l o r v a u l t prolapse. Table I . Outcome of hydronephrosis in patients with severe uterovaginal or vault prolapse (n = 25).
this was not possible to enforce in our cohort, as some patients defaulted on their renal ultrasonography appointments and had to be rescheduled.
To conclude, the local incidence of hydronephrosis in patients with severe uterovaginal or vault prolapse was 20.6% in our study.
3.3% of women with severe uterovaginal or vault prolapse had mild renal impairment. In the majority of patients, treatment for severe uterovaginal or vault prolapse by vaginal surgery resulted in either complete resolution or improvement of hydronephrosis.
Studies with longer follow-up periods and larger sample sizes are needed to further corroborate the results of this study.
